Cancer - neuroblastoma
Neuroblastoma is a very rare type of cancerous tumor that develops from nerve tissue. It usually occurs in infants and children.
Neuroblastoma can occur in many areas of the body. It develops from the tissues that form the sympathetic nervous system. This is the part of the nervous system that controls body functions, such as heart rate and blood pressure, digestion, and levels of certain hormones.
Most neuroblastomas begin in the abdomen, in the adrenal gland, next to the spinal cord, or in the chest. Neuroblastomas can spread to the bones. Bones include those in the face, skull, pelvis, shoulders, arms, and legs. It can also spread to the bone marrow, liver, lymph nodes, skin, and around the eyes (orbits).
The cause of the tumor is not known. Experts believe that a defect in a gene may play a role. Half of tumors are present at birth. Neuroblastoma is most commonly diagnosed in children before the age of 5. Each year there are around 700 new cases in the United States. The disorder is slightly more common in boys.
In most people, the tumor has spread when it is first diagnosed.
The first symptoms are usually fever, a general sick feeling (malaise), and pain. There may also be loss of appetite, weight loss, and diarrhea.
Other symptoms depend on the site of the tumor, and may include:
Bone pain or tenderness (if the cancer has spread to the bones)
Difficulty breathing or a chronic cough (if the cancer has spread to the chest)
Enlarged abdomen (from a large tumor or excess fluid)
Flushed, red skin
Pale skin and bluish color around the eyes
Rapid heart rate (tachycardia)
Brain and nervous system problems may include:
Exams and Tests
The health care provider will examine the child. Depending on the location of the tumor:
There may be a lump or mass in the abdomen.
The liver may be enlarged, if the tumor has spread to the liver.
There may be high blood pressure and a fast heart rate if the tumor is in an adrenal gland.
Lymph nodes may be swollen.
X-ray or other imaging tests are done to locate the main (primary) tumor and to see where it has spread. These include:
Other tests that may be done include:
Biopsy of tumor
Bone marrow biopsy
Complete blood count (CBC) showing anemia or other abnormality
Coagulation studies and erythrocyte sedimentation rate (ESR)
Hormone tests (blood tests to check levels of hormones such as catecholamines)
MIBG scan (imaging test to confirm the presence of neuroblastoma)
Urine 24-hour test for catecholamines, homovanillic acid (HVA), and vanillylmandelic acid (VMA)
Treatment depends on:
Location of the tumor
How much and where the tumor has spread
The person's age
In certain cases, surgery alone is enough. Often, though, other therapies are needed as well. Anticancer medicines (chemotherapy) may be recommended if the tumor has spread. Radiation therapy may also be used.
You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you and your child not feel alone.
Outcome varies. In very young children, the tumor may go away on its own, without treatment. Or, the tissues of the tumor may mature and develop into a non-cancerous (benign) tumor called a ganglioneuroma, which can be surgically removed. In other cases, the tumor spreads quickly.
Response to treatment also varies. Treatment is often successful if the cancer has not spread. If it has spread, neuroblastoma is harder to cure. Younger children often do better than older children.
Children treated for neuroblastoma may be at risk of getting a second, different cancer in the future.
Complications may include:
Spread (metastasis) of the tumor
Damage and loss of function of involved organs
When to Contact a Medical Professional
Contact your provider if your child has symptoms of neuroblastoma. Early diagnosis and treatment improves the chance of a good outcome.
Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Pediatric solid tumors. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 92.
National Cancer Institute website. Neuroblastoma treatment (PDQ) - health professional version.
Last reviewed on: 10/16/2022
Reviewed by: Mark Levin, MD, Hematologist and Oncologist, Monsey, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 05/01/2023.